Aclaris Therapeutics Inc. – Plans of Reorganization, Merger, Acquisition or Similar

NASDAQ: ACRS
Share price (6/3/26): $4.42
Market cap (6/3/26): $617 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

from 8-K 58 pages Asset Purchase Agreement by and Between Aclaris Therapeutics, Inc. and Epi Health, LLC Certain Identified Information Has Been Excluded From This Exhibit Because It Is Both (I) Not Material and (II) Would Be Competitively Harmful if Publicly Disclosed. Omissions Are Designated [***]

from 8-K 78 pages Asset Purchase Agreement by and Between Aclaris Therapeutics, Inc., as Buyer and Allergan Sales, LLC, as Seller Dated as of October 15, 2018

from 10-Q 81 pages Agreement and Plan of Merger by and Among Aclaris Therapeutics, Inc., Aclaris Life Sciences, Inc., Confluence Life Sciences, Inc. And, Solely in Its Capacity as Company Equityholder Representative, Fortis Advisors LLC Dated as of August 3, 2017

from 10-Q 57 pages Stock Purchase Agreement